Radiotherapy in low-grade glioma adult patients: A retrospective survival and neurocognitive toxicity analysis

Radiologia Medica

Volumn 119, Issue 6, 2014, Pages 432-439

  Buglione, Michela ^a   Pedretti, Sara ^a   Gipponi, Stefano ^b   Todeschini, Alice ^b   Pegurri, Ludovica ^a   Costa, Loredana ^a   Donadoni, Laura ^a   Grisanti, Salvatore ^c   Fontanella, Marco ^b   Liserre, Roberto ^b   Facchetti, Fabio ^c   Padovani, Alessandro ^b   Magrini, Stefano Maria ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c SPEDALI CIVILI   (Italy)

Author keywords

Low grade glioma; Neurocognitive evaluation; Radiotherapy; Survival

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN TUMOR; COGNITIVE DEFECT; FEMALE; GLIOMA; HUMAN; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; BRAIN NEOPLASMS; COGNITION DISORDERS; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84902131195     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11547-013-0347-y     Document Type: Article

References (48)

1. Ducray F (2008) Biology of gliomas. Cancer Radiother 12:663-668
2. DeAngelis ML (2001) Brain tumors. N Engl J Med 344:114-123 (Pubitemid 32052502)
3. David NL, Hiroko O, Otmar DW et al (2007) The 2007 WHO classification of tumors of the central nervous system. Acta Neuropathol 114:97-109 (Pubitemid 47103521)
4. Chang E, Smith JS, Chang SM et al (2008) Preoperative prognostic classification system for hemispheric low-grade gliomas in adults. J Neurosurg 109:817-824
5. Bauman G, Fisher B, Watling C et al (2009) Adult supratentorial low-grade glioma: long-term experience at a single institution. Int J Radiat Oncol Biol Phys 75:1401-1407
6. Schiff D, Brown PD, Giannini C (2007) Outcome in adult low-grade glioma: the impact of prognostic factors and treatment. Neurology 69:1366-1373 (Pubitemid 47482451)
7. Smith JS, Perry A, Borell TJ et al (2000) Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 18:636-645 (Pubitemid 30078545)
8. Kujas M, Lejeune J, Benouaich-Amiel A et al (2005) Chromosome 1p loss: a favorable prognostic factor in low-grade gliomas. Ann Neurol 58:322-326 (Pubitemid 41098891)
9. Weller M, Berger H, Hartmann C et al (2007) Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker? Clin Cancer Res 13:6933-6937 (Pubitemid 350276872)
10. Keles GV, Lamborn KR, Berger MS (2001) Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg 95:735-745 (Pubitemid 33043344)
11. McGirt MJ, Chaichana KL, Attenello FJ et al (2008) Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery 63:700-707
12. Smith JS, Chang EF, Lamborn KR et al (2008) Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 26:1338-1345
13. Van den Bent MJ, Afra D, de Witte O et al (2005) Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 366:985-990 (Pubitemid 41323034)
14. Shaw E, Arusell R, Scheithauer B et al (2002) Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 20:2267-2276 (Pubitemid 34441653)
15. Karim AB, Maat B, Hatlevoll R et al (1996) A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 36:549-556 (Pubitemid 26404297)
16. Kaloshi G, Benouaich-Amiel A, Diakite F et al (2007) Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology 68:1831-1836 (Pubitemid 46791397)
17. Bauman G, Lote K, Larson D et al (1999) Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis. Int J Radiat Oncol Biol Phys 45:923-929 (Pubitemid 29525456)
18. Ware JE, Kosinski M, Keller SD (1996) SF-12: how to score the SF-12 physical and mental health summary scales. Med Care
19. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
20. Cummings JL, Mega M, Gray K et al (1994) The neuropsychiatric inventory. Neurology 44:2308-2314
21. Carlesimo GA, Caltagirone C, Gainotti G et al (1996) The mental deterioration battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. Eur Neurol 36:378-384 (Pubitemid 26343685)
22. Rey A (1958) Mémorisation d'une serie de 15 mots en 5 répétitions. In: Rey A (ed) L'examen clinique en psychologie. Presses Universitaires de France, Paris, pp 139-193
23. Reitan RM (1958) Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 8:271-276
24. Corrigan JD, Hinkeldey MS (1987) Relationships between parts A and B of the trail making test. J Clin Psychol 43:402-409 (Pubitemid 17107000)
25. Gaudino EA, Geisler MW, Squires NK (1995) Construct validity in the trail making test: what makes Part B harder? J Clin Exp Neuropsychol 17:529-535
26. Shulman KI (2000) Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry 15:548-561 (Review) (Pubitemid 30410000)
27. Samton JB, Ferrando SJ, Sanelli P et al (2005) The clock drawing test: diagnostic, functional, and neuroimaging correlates in older medically ill adults. J Neuropsychiatry Clin Neurosci 17:533-540 (Pubitemid 41790055)
28. Karim ABMF, Afra D, Cornu P et al (2002) Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys 52:316-324 (Pubitemid 34170840)
29. Surma-aho O, Niemela M, Vilkki J et al (2001) Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients. Neurology 56:1285-1290 (Pubitemid 32455284)
30. Taphoorn MJ, Schiphorst AK, Snoek FJ et al (1994) Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy. Ann Neurol 36:48-54 (Pubitemid 24205823)
31. Laack NN, Brown PD, Ivnik RJ et al (2005) Cognitive function after radiotherapy for supratentorial low-grade glioma: a North Central Cancer Treatment Group prospective study. Int J Radiat Oncol Biol Phys 63:1175-1183 (Pubitemid 41505297)
32. Pouratian N, Gasco J, Sherman JH et al (2007) Toxicity and efficacy of protracted low dose temozolomide for the treatment of low grade gliomas. J Neurooncol 82:281-288 (Pubitemid 46614391)
33. Soffietti R, Ruda R, Bradac GB et al (1998) PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas. Neurosurgery 43:1066-1073 (Pubitemid 28481106)
34. Van den Bent MJ, Kros JM, Heimans JJ et al (1998) Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group. Neurology 51:1140-1145 (Pubitemid 28473415)
35. Shaw EG, Wang M, Coons S et al (2008) Final report of radiation therapy oncology group (RTOG) protocol 9802: radiation therapy (RT) versus RT + procarbazine, CCNU and vincristine (PCV) chemotherapy for adult low grade gliomas (LGG). J Clin Oncol (Meeting Abstracts) 26(15S):2006
36. Brada M, Viviers L, Abson C et al (2003) Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol 14:1715-1721 (Pubitemid 38029041)
37. Buckner JC, Gesme D, O'Fallon JR et al (2003) Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities. J Clin Oncol 21:251-255 (Pubitemid 46606153)
38. Duffau H, Taillandier L, Capelle L et al (2006) Radical surgery after chemotherapy: a new therapeutic strategy to envision in grade II glioma. J Neurooncol 80:171-176 (Pubitemid 44614799)
39. Frenay MP, Fontaine D, Vandenbos F et al (2005) First-line nitrosourea-based chemotherapy in symptomatic non resectable supratentorial pure low-grade astrocytomas. Eur J Neurol 12:685-690 (Pubitemid 41297830)
40. Sanders WP, Christoforidis GA (1999) Imaging of low-grade primary brain tumors. In: Rock JP, Rosenblum ML, Shaw EG, Cairncross JG (eds) The practical management of low-grade primary brain tumors. Lippincott Williams & Wilkins, Philadelphia, pp 5-32
41. Law M, Yang S, Wang H et al (2003) Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. Am J Neuroradiol 24:1989-1998 (Pubitemid 37444849)
42. Zonari P, Baraldi P, Crisi G (2007) Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging. Neuroradiology 49:795-803 (Pubitemid 47497767)
43. Danchaivijitr N, Waldman AD, Tozer DJ et al (2008) Low grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation? Radiology 247:170-178
44. Tucha O, Smely C, Preier M et al (2000) Cognitive deficits before treatment among patients with brain tumors. Neurosurgery 47:324-333 (Pubitemid 32049338)
45. Douw L, Klein M, Fagel SS et al (2009) Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. Lancet Neurol 8:810-818
46. Lawrence YR, Li XA et al (2010) Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 76(suppl 3):S20-S27
47. Mayo C, Yorke E, Merchant TE (2010) Radiation associated brainstem injury. Int J Radiat Oncol Biol Phys 76(suppl 3):S36-S41
48. Magrini SM, Ricardi U, Santoni R et al (2006) Pattern of care and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985-2001 in 12 Italian Radiation Oncology Centres. Int J Radiat Oncol Biol Phys 65(3):788-799 (Pubitemid 43795845)